ABSTRACT
BACKGROUND: The International epidemiology Databases to Evaluate AIDS conducts research in several regions, including in Southern Africa. We assessed authorship inequalities for the Southern African region, which is led by South African and Swiss investigators. METHODS: We analysed authorships of publications from 2007 to 2020 by gender, country income group, time and citation impact. We used 2020 World Bank categories to define income groups and the relative citation ratio (RCR) to assess citation impact. Authorship parasitism was defined as articles without authors from the countries where the study was conducted. A regression model examined the probability of different authorship positions. RESULTS: We included 313 articles. Of the 1064 contributing authors, 547 (51.4%) were women, and 223 (21.0%) were from 32 low-income/lower middle-income countries (LLMICs), 269 (25.3%) were from 13 upper middle-income countries and 572 (53.8%) were from 25 high-income countries (HICs). Most articles (150/157, 95.5%) reporting data from Southern Africa included authors from all participating countries. Women were more likely to be the first author than men (OR 1.74; 95% CI 1.06 to 2.83) but less likely to be last authors (OR 0.63; 95% CI 0.40 to 0.99). Compared with HIC, LLMIC authors were less likely to publish as first (OR 0.21; 95% CI 0.11 to 0.41) or last author (OR 0.20; 95% CI 0.09 to 0.42). The proportion of women and LLMIC first and last authors increased over time. The RCR tended to be higher, indicating greater impact, if first or last authors were from HIC (p=0.06). CONCLUSIONS: This analysis of a global health collaboration co-led by South African and Swiss investigators showed little evidence of authorship parasitism. There were stark inequalities in authorship position, with women occupying more first and men more last author positions and researchers from LLMIC being 'stuck in the middle' on the byline. Global health research collaborations should monitor, analyse and address authorship inequalities.
Subject(s)
Authorship , Global Health , Male , Humans , Female , Publishing , Income , Africa, SouthernABSTRACT
BACKGROUND: Vaccination may control the coronavirus disease 2019 (COVID-19) pandemic, including in nursing homes where many high-risk people live. We conducted extensive outbreak investigations. METHODS: We studied an outbreak at a nursing home in Switzerland, where the uptake of messenger RNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was 82% among residents as of 21 January 2021. After diagnosis of COVID-19 in a vaccinated symptomatic healthcare worker (HCW) on 22 February, we performed outbreak investigations in house A (47 residents; 37 HCWs), using SARS-CoV-2-specific polymerase chain reaction testing of nasopharyngeal swab samples. We performed whole-genome sequencing of SARS-CoV-2 and serological analyses. RESULTS: We identified 17 individuals with positive polymerase chain reaction results, 10 residents (5 vaccinated) and 7 HCWs (3 vaccinated). The median age (interquartile range) was 86 (70-90) years among residents and 49 (29-59) years among HCWs. Of the 5 vaccinated residents, 3 had mild disease and 2 had no symptoms, whereas all 5 unvaccinated residents had mild to severe disease, and 2 died. Vaccine effectiveness for the prevention of infection among residents was 73.0% (95% confidence interval, 24.7%-90.1%). The 12 available genomes were all alpha variants. Neutralizing titers were significantly higher in vaccinated individuals on reexposure (>1 week after diagnosis) than in vaccinated, unexposed HCWs (Pâ =â .01). Transmission networks indicated 4 likely or possible transmissions from vaccinated to other individuals and 12 transmission events from unvaccinated individuals. CONCLUSIONS: COVID-19 outbreaks can occur in nursing homes, including transmission from vaccinated persons to others. Outbreaks might occur silently, underlining the need for continued testing and basic infection control measures in these high-risk settings.
Subject(s)
COVID-19 , Vaccination Coverage , Humans , Aged, 80 and over , COVID-19/epidemiology , COVID-19/prevention & control , SARS-CoV-2/genetics , Nursing Homes , Disease Outbreaks/prevention & control , VaccinationABSTRACT
Evidence on the use and efficacy of medical cannabis for children is limited. We examined clinical and epidemiological characteristics of medical cannabis treatment and caregiver-reported effects in children and adolescents in Switzerland. We collected clinical data from children and adolescents (< 18 years) who received Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), or a combination of the two between 2008 and 2019 in Switzerland. Out of 205 contacted families, 90 agreed to participate. The median age at the first prescription was 11.5 years (interquartile range (IQR) 6-16), and 32 patients were female (36%). Fifty-one (57%) patients received CBD only and 39 (43%) THC. Patients were more likely to receive THC therapy if one of the following symptoms or signs were present: spasticity, pain, lack of weight gain, vomiting, or nausea, whereas seizures were the dominant indication for CBD therapy. Improvements were reported in 59 (66%) study participants. The largest treatment effects were reported for pain, spasticity, and frequency of seizures in participants treated with THC, and for those treated with pure CBD, the frequency of seizures. However, 43% of caregivers reported treatment interruptions, mainly because of lack of improvement (56%), side effects (46%), the need for a gastric tube (44%), and cost considerations (23%).Conclusions: The effects of medical cannabis in children and adolescents with chronic conditions are unknown except for rare seizure disorders, but the caregiver-reported data analysed here may justify trials of medical cannabis with standardized concentrations of THC or CBD to assess its efficacy in the young. What is Known: ⢠The use of medical cannabis (THC and CBD) to treat a variety of diseases among children and adolescents is increasing. ⢠In contrast to adults, there is no evidence to support the use of medical cannabis to treat chronic pain and spasticity in children, but substantial evidence to support the use of CBD in children with rare seizure disorders. What is New: ⢠This study provides important insights into prescription practices, dosages, and treatment outcomes in children and adolescents using medical cannabis data from a real-life setting. ⢠The effects of medical cannabis in children and adolescents with chronic conditions shown in our study support trials of medical cannabis for chronic conditions.
Subject(s)
Cannabis , Chronic Pain , Medical Marijuana , Adolescent , Adult , Caregivers , Child , Dronabinol/therapeutic use , Female , Humans , Medical Marijuana/therapeutic use , SwitzerlandABSTRACT
INTRODUCTION: The rise of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTI) threatens antiretroviral therapy's long-term success (ART). NNRTIs will remain an essential drug for the management of HIV-1 due to safety concerns associated with integrase inhibitors. We fitted a dynamic transmission model to historical data from 2000 to 2018 in nine countries of southern Africa to understand the mechanisms that have shaped the HIV-1 epidemic and the rise of pretreatment NNRTI resistance. METHODS: We included data on HIV-1 prevalence, ART coverage, HIV-related mortality, and survey data on pretreatment NNRTI resistance from nine southern Africa countries from a systematic review, UNAIDS and World Bank. Using a Bayesian hierarchical framework, we developed a dynamic transmission model linking data on the HIV-1 epidemic to survey data on NNRTI drug resistance in each country. We estimated the proportion of resistance attributable to unregulated, off-programme use of ART. We examined each national ART programme's vulnerability to NNRTI resistance by defining a fragility index: the ratio of the rate of NNRTI resistance emergence during first-line ART over the rate of switching to second-line ART. We explored associations between fragility and characteristics of the health system of each country. RESULTS: The model reliably described the dynamics of the HIV-1 epidemic and NNRTI resistance in each country. Predicted levels of resistance in 2018 ranged between 3.3% (95% credible interval 1.9-7.1) in Mozambique and 25.3% (17.9-33.8) in Eswatini. The proportion of pretreatment NNRTI resistance attributable to unregulated antiretroviral use ranged from 6% (2-14) in Eswatini to 64% (26-85) in Mozambique. The fragility index was low in Botswana (0.01; 0.0-0.11) but high in Namibia (0.48; 0.16-10.17), Eswatini (0.64; 0.23-11.8) and South Africa (1.21; 0.83-9.84). The combination of high fragility of ART programmes and high ART coverage levels was associated with a sharp increase in pretreatment NNRTI resistance. CONCLUSIONS: This comparison of nine countries shows that pretreatment NNRTI resistance can be controlled despite high ART coverage levels. This was the case in Botswana, Mozambique, and Zambia, most likely because of better HIV care delivery, including rapid switching to second-line ART of patients failing first-line ART.
Subject(s)
HIV Infections , HIV-1 , Bayes Theorem , DNA-Directed RNA Polymerases , Drug Resistance, Viral , HIV Infections/drug therapy , HIV Infections/epidemiology , HIV-1/genetics , Humans , South AfricaABSTRACT
BACKGROUND: Uncertainty about cure puts childhood cancer survivors at risk of mental distress. We asked survivors if they had been told they had been cured and investigated associated factors. PROCEDURE: We used nationwide registry data and a questionnaire survey for ≥five-year survivors of childhood cancer (n = 301), followed by online focus groups with a purposive sample of Swiss pediatric oncologists (n = 17). Discussions were coded by investigators using thematic analysis. RESULTS: Overall, 235 among 301 survivors (78%; 95% confidence interval, 73%-83%) reported having been told they were cured. The proportion was 89% (81%-97%) among lymphoma and 84% (77%-91%) among leukemia survivors, but only 49% (33%-65%) among central nervous system tumor survivors. Pediatric oncologists acknowledged that telling survivors they are cured may reassure them that their cancer lies behind them. However, many refrained from telling all patients. Reasons included the possibility of late effects (cure disrupted by a continued need for follow-up care) or late relapse (uncertainty of biological cure), case-by-case strategies (use of "cure" according to individual factors), and reluctance (substitution of noncommittal terms for "cure"; waiting for the patient to raise the topic). CONCLUSIONS: Not all physicians tell survivors they have been cured; their choices depend on the cancer type and risk of late effects.
Subject(s)
Aftercare/standards , Cancer Survivors/psychology , Delivery of Health Care/standards , Health Communication/methods , Neoplasms/prevention & control , Neoplasms/psychology , Oncologists/standards , Adolescent , Adult , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Male , Prognosis , Registries/statistics & numerical data , Surveys and Questionnaires , Young AdultABSTRACT
Regulation of tissue size requires fine tuning at the single-cell level of proliferation rate, cell volume, and cell death. Whereas the adjustment of proliferation and growth has been widely studied [1-5], the contribution of cell death and its adjustment to tissue-scale parameters have been so far much less explored. Recently, it was shown that epithelial cells could be eliminated by live-cell delamination in response to an increase of cell density [6]. Cell delamination was supposed to occur independently of caspase activation and was suggested to be based on a gradual and spontaneous disappearance of junctions in the delaminating cells [6]. Studying the elimination of cells in the midline region of the Drosophila pupal notum, we found that, contrary to what was suggested before, Caspase 3 activation precedes and is required for cell delamination. Yet, using particle image velocimetry, genetics, and laser-induced perturbations, we confirmed [6] that local tissue crowding is necessary and sufficient to drive cell elimination and that cell elimination is independent of known fitness-dependent competition pathways [7-9]. Accordingly, activation of the oncogene Ras in clones was sufficient to compress the neighboring tissue and eliminate cells up to several cell diameters away from the clones. Mechanical stress has been previously proposed to contribute to cell competition [10, 11]. These results provide the first experimental evidences that crowding-induced death could be an alternative mode of super-competition, namely mechanical super-competition, independent of known fitness markers [7-9], that could promote tumor growth.
Subject(s)
Apoptosis , Caspase 3/genetics , Drosophila Proteins/genetics , Drosophila melanogaster/growth & development , Animals , Cell Adhesion , Cell Proliferation , Drosophila Proteins/metabolism , Drosophila melanogaster/genetics , Drosophila melanogaster/metabolism , Pupa/genetics , Pupa/growth & development , Pupa/metabolismABSTRACT
The large amounts of insecticides used for crop protection lead to widespread environmental pollution. Determination of the potential impacts induced by this contamination on key species involved in the equilibrium of ecosystems is therefore a necessity. In this study, we tested the effects of a pyrethroid insecticide, deltamethrin, on the capacity of males from two sympatric Trichogramma species to discriminate the sex pheromones emitted by females of their own species (Trichogramma are parasitoids of Lepidopterous). The impact of an acute exposure as could occur at field edges was evaluated using a dose inducing 20% mortality (LD 20). The impact of a low exposure corresponding to diffuse environmental pollution was evaluated by applying an LD 0.1 (a dose inducing no apparent mortality). For T. semblidis, deltamethrin decreased the specific recognition of sexual pheromones at the higher dose (LD 20) but had no effect on this recognition at the lower dose (LD 0.1). However, deltamethrin decreased the saturation of pheromone receptors at both doses. For T. evanescens, deltamethrin increased the recognition of sexual pheromones at both doses, though not during the same period of observation (at the beginning for the LD 20, at the end for the LD 0.1), but it did not decrease the saturation of the pheromone receptors. These differing results were analyzed considering the behavior of the insects, their level of sensitivity to the insecticide and its mode of action. They provide new insights regarding possible consequences of environmental pollution by insecticides on functional biodiversity.
Subject(s)
Environmental Pollutants/toxicity , Hymenoptera/drug effects , Nitriles/toxicity , Pyrethrins/toxicity , Sex Attractants/metabolism , Animals , Female , Kinetics , Male , Receptors, Pheromone/drug effectsABSTRACT
Trichogramma are used for the biological control of numerous pests. For Trichogramma, as for other insects, the specificity of matings is ensured by several barriers that prevent copulation attempts between insects from different species. We have recently shown that insecticides may totally suppress species recognition that occurs from pheromonal communications between two Trichogramma species, a sublethal effect that will increase mating attempts between two different species. In this work, we have assessed the fitness cost of such interspecific matings and demonstrate that they are very costly for females. After an interspecific mating, females can generate only males because fertilized eggs degenerate (Trichogramma are haplo-diploid species; males are issued from unfertilized eggs and females from fertilized eggs). The resulting offspring are reduced in number by more than half, corresponding to the missing progeny from fertilized eggs. After an interspecific mating, the fecundity of females cannot be restored even if females subsequently mate intraspecifically. These results highlight the strong fitness cost of any event that would decrease the specificity of matings in Trichogramma. Because Trichogramma are key species regulating insect populations, these effects must be considered in the context of sustainable development.